Does Caffeine Reduce Dipyridamole-Induced Protection Against Ischemia-Reperfusion Injury?

NCT00430170 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Cardiovascular Disease
Ischemia-Reperfusion Injury

Interventions

DRUG: Dipyridamole
DRUG: caffeine

Sponsor

Radboud University Medical Center